Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma
- 1 May 1986
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 64 (5) , 768-774
- https://doi.org/10.3171/jns.1986.64.5.0768
Abstract
The distribution, retention, and phototoxicity of the sensitizer hematoporphyrin derivative (HPD) were studied following intraperitoneal and direct intraneoplastic injections of the agent into subcutaneous or intracerebral gliosarcomas in rats. Forty-eight hours after intraperitoneal injection, the ratio of tritiated (3H) HPD in subcutaneous tumor: adjacent normal skin was about 1.4:1 and the ratio in tumor: normal brain was 3:1. In contrast, direct injection of 3H-HPD into subcutaneous tumors resulted in tumor: adjacent normal skin concentration ratios of approximately 44:1 and tumor: normal brain ratios of about 61:1. For rats bearing intracerebral gliosarcomas, intraperitoneal administration of 3H-HPD resulted in approximately 1.3-fold sensitization in tumor tissue relative to adjacent edematous brain. In contrast, after direct injection into intracerebral tumors, the tumor: adjacent edematous brain and tumor: skin 3H-HPD ratios were 3:1 and 32:1, respectively. In all cases, 3H-HPD was found in every portion of the tumor, even at a distance from the injection site. For the 3H-HPD doses used in this study, after direct injection both subcutaneous and intracerebral tumor tissue contained about three to four times more 3H-HPD than tumors in rats receiving intraperitoneal 3H-HPD. Both in vitro and in vivo clonogenic assays demonstrated that the photodynamic inactivation of the tumors was significantly greater after direct injection than after intraperitoneal injection.Keywords
This publication has 13 references indexed in Scilit:
- Quantitation of Hematoporphyrin Derivative in Human Gliomas, Experimental Central Nervous System Tumors, and Normal TissuesNeurosurgery, 1983
- Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissuesNeurosurgery, 1983
- Development of a protocol for photoradiation therapy of malignant brain tumorsNeurosurgery, 1982
- Development of a Protocol for Photoradiation Therapy of Malignant Brain Tumors: Part 1Neurosurgery, 1982
- New Implantable Continuous Administration and Bolus Dose Intracarotid Drug Delivery System for the Treatment of Malignant GliomasNeurosurgery, 1982
- Photoradiation Therapy in the Treatment of Malignant Brain TumorsNeurosurgery, 1981
- Production of Hydroxyl Radicals in Cell Systems Exposed to Haematoporphyrin and Red LightInternational Journal of Radiation Biology, 1980
- Photosensitization by hematoporphyrin: ESR evidence for free radical induction in unsaturated fatty acids and for singlet oxygen productionBiochemical and Biophysical Research Communications, 1977
- Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapyJournal of Neurosurgery, 1977
- Hematoporphyrin fluorescence: An aid in diagnosis of malignant neoplasmsThe Laryngoscope, 1971